A rules-based approach to trading SPY put credit spreads with a 91%+ win rate. Entry rules, exit targets, position sizing, and the 2025 drawdown-to-recovery story with real numbers.
Related To: Options Trading
A complete guide to selling covered calls for income, with real trade examples, strike selection rules, and how covered calls fit into the wheel strategy.
AFRM rated Hold with $65 target (+33%). First-ever GAAP profit, 30% revenue growth, but zero insider buys across 85 transactions. 8-week base forming.
META rated Buy with $750 target (+22.5%). $201B revenue +22%, FoA 51.6% margin, $46B FCF, PEG 0.91. Bill Ackman buying. CFO sold $88M Feb.
AMZN rated Hold with $240 target (+15%). $717B revenue growing 12%, AWS +20%, but $128B AI capex collapsed FCF 71%. Wait for Q1 earnings clarity.
ALK rated Buy with $55 target (+52%). Crashed 54% on Iran/oil panic. 6.7x adj P/E, 0.7x P/B, $5.40 adjusted EPS. Hawaiian synergies coming.
DIS rated Buy with $120 target (+21%). 14.5x P/E, $18B OCF, parks +6% growth. Director Gorman buying $4.1M personally. CEO transition risk.
IONQ rated Hold with $34 target (+3%). Revenue tripled to $130M but 93x P/S, negative margins, and $335M coordinated insider selling.
RIVN rated Hold with $16 target (+8%). First gross profit year, R2 launching Q2 2026, but execution risk and cash burn remain concerns.
SMMT rated Speculative Hold. Binary FDA bet on ivonescimab — bull case $28-35, bear case $3-5. PDUFA Nov 14, 2026.
